0001710380-25-000005.txt : 20250926
0001710380-25-000005.hdr.sgml : 20250926
20250926141202
ACCESSION NUMBER: 0001710380-25-000005
CONFORMED SUBMISSION TYPE: D/A
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06c
FILED AS OF DATE: 20250926
DATE AS OF CHANGE: 20250926
EFFECTIVENESS DATE: 20250926
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Angiex, Inc.
CENTRAL INDEX KEY: 0001710380
ORGANIZATION NAME:
EIN: 810865944
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-554765
FILM NUMBER: 251349448
BUSINESS ADDRESS:
STREET 1: 150 CAMBRIDGE PARK DRIVE, SUITE 5
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
BUSINESS PHONE: 6175761753
MAIL ADDRESS:
STREET 1: 150 CAMBRIDGE PARK DRIVE, SUITE 5
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
D/A
1
primary_doc.xml
X0708
D/A
LIVE
0001710380
Angiex, Inc.
150 Cambridge Park Drive, 5th Floor
CAMBRIDGE
MA
MASSACHUSETTS
02140
857-203-7808
DELAWARE
None
None
Corporation
true
Paul
Jaminet
150 Cambridge Park Drive, 5th Floor
Cambridge
MA
MASSACHUSETTS
02140
Executive Officer
Director
Amal
Amin
150 Cambridge Park Drive, 5th Floor
Cambridge
MA
MASSACHUSETTS
02140
Director
Jason
Camm
150 Cambridge Park Drive 5th Floor
Cambridge
MA
MASSACHUSETTS
02140
Director
Haijing
Guo
150 Cambridge Park Drive, 5th Floor
Cambridge
MA
MASSACHUSETTS
02140
Director
Fabian
Hansen
150 Cambridge Park Drive, 5th Floor
Cambridge
MA
MASSACHUSETTS
02140
Director
Tina
Neel
150 Cambridge Park Drive, 5th Floor
Cambridge
MA
MASSACHUSETTS
02140
Director
Jonathan
Adams
150 Cambridge Park Drive, 5th Floor
Cambridge
MA
MASSACHUSETTS
02140
Director
Iain
Dukes
150 Cambridge Park Drive, 5th Floor
Cambridge
MA
MASSACHUSETTS
02140
Director
Errik
Anderson
150 Cambridge Park Drive, 5th Floor
Cambridge
MA
MASSACHUSETTS
02140
Director
Biotechnology
Decline to Disclose
- 06c
true
0001710380-25-000003
2025-07-31
false
true
true
true
false
0
Paulson Investment Company, LLC
5670
10220 SW Greenburg Road, Suite 380
None
10220 SW Greenburg Road, Suite 380
Portland
OR
OREGON
97223
All States
false
28409510
21991695
6417815
Total amount sold include $2,877,002.24 of converted indebtedness and current interest; and $8,064,117.91 of aggregate value of Warrants to purchase common stock.
false
137
0
2432708
true
0
false
Angiex, Inc.
/s/ Paul Jaminet
Paul Jaminet
Chief Executive Officer
2025-09-26